Regeneron Pharmaceuticals (REGN) Advances Allergy Pipeline with Two Positive Phase 3 Trials Evaluating First-in-Class Antibody-Blockers of Cat and Birch Allergies
YahooNoor Ul Ain Rehman
Regeneron Pharmaceuticals (REGN) Advances Allergy Pipeline with Two Positive Phase 3 Trials Evaluating First-in-Class Antibody-Blockers of Cat and Birch Allergies
Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN) is one of best affordable biotech stocks to invest in now. Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN) announced on September 8 the results evaluating “its first-in-class investigational allergen-blocking antibodies in allergen-challenge Phase 3 trials in adults with moderate-to-severe cat or ...
3 weeks ago
Regeneron Stock Analysis
Tech Trailblazers Ep. 1 | Exploring Immune Responses in Gene Therapy Delivery with Andrew Baik
0:48
Tech Trailblazers Ep. 1 | Exploring Immune Responses in Gene Therapy Delivery with Andrew Baik
YouTubeRegeneron
95 views3 weeks ago
Tech Trailblazers Ep. 1 | Exploring Immune Responses in Gene Therapy Delivery with Andrew Baik
0:38
Tech Trailblazers Ep. 1 | Exploring Immune Responses in Gene Therapy Delivery with Andrew Baik
YouTubeRegeneron
154 views3 weeks ago
Tech Trailblazers Ep. 1 | Exploring Immune Responses in Gene Therapy Delivery with Andrew Baik
0:41
Tech Trailblazers Ep. 1 | Exploring Immune Responses in Gene Therapy Delivery with Andrew Baik
YouTubeRegeneron
234 views3 weeks ago
Top videos
The U.S. FDA approved our medicine to treat children aged one to less than five years old with #HoFH (homozygous familial hypercholesterolemia), an ultra-rare inherited condition that results in extremely high levels of LDL-C. The approval underscores the importance of early diagnosis and care, including for some of the youngest people living with HoFH. Learn more: https://bit.ly/3IHu3Mg | Regeneron
The U.S. FDA approved our medicine to treat children aged one to less than five years old with #HoFH (homozygous familial hypercholesterolemia), an ultra-rare inherited condition that results in extremely high levels of LDL-C. The approval underscores the importance of early diagnosis and care, including for some of the youngest people living with HoFH. Learn more: https://bit.ly/3IHu3Mg | Regeneron
FacebookRegeneron
2K views2 weeks ago
Regeneron Covid-19 'antibody cocktail' drug enters late-stage trials
2:18
Regeneron Covid-19 'antibody cocktail' drug enters late-stage trials
CNBCMeg Tirrell
Jul 6, 2020
6.8K views · 17 reactions | Strolling through the week like... | Regeneron | Facebook
0:06
6.8K views · 17 reactions | Strolling through the week like... | Regeneron | Facebook
FacebookRegeneron
6.9K views1 week ago
Regeneron Science Talent Search
The Founding of Regeneron Pharmaceuticals in 1988: A Scientific Revolution
0:49
The Founding of Regeneron Pharmaceuticals in 1988: A Scientific Revolution
YouTubeAmerican History 101
180 views7 months ago
Regeneron’s Eylea Nabs First Pediatric Approval for Eye Disease in Preterm Infants
0:39
Regeneron’s Eylea Nabs First Pediatric Approval for Eye Disease in Preterm Infants
YouTubeXtalks
1.1K viewsFeb 10, 2023
With Lynozyfic Approval, Regeneron Takes On J&J and Pfizer in Bispecific Myeloma Space
0:31
With Lynozyfic Approval, Regeneron Takes On J&J and Pfizer in Bispecific Myeloma Space
YouTubeXtalks
155 views3 months ago
The U.S. FDA approved our medicine to treat children aged one to less than five years old with #HoFH (homozygous familial hypercholesterolemia), an ultra-rare inherited condition that results in extremely high levels of LDL-C. The approval underscores the importance of early diagnosis and care, including for some of the youngest people living with HoFH. Learn more: https://bit.ly/3IHu3Mg | Regeneron
The U.S. FDA approved our medicine to treat children aged on…
2K views2 weeks ago
FacebookRegeneron
Regeneron Covid-19 'antibody cocktail' drug enters late-stage trials
2:18
Regeneron Covid-19 'antibody cocktail' drug enters late-stage trials
Jul 6, 2020
CNBCMeg Tirrell
6.8K views · 17 reactions | Strolling through the week like... | Regeneron | Facebook
0:06
6.8K views · 17 reactions | Strolling through the week like... | Regener…
6.9K views1 week ago
FacebookRegeneron
4.6K views · 115 reactions |  Yesterday we announced our plans to...
0:43
4.6K views · 115 reactions |  Yesterday we announced our plan…
2K views3 weeks ago
FacebookRegeneron
Patients are the key to our clinical trial success. Our Regeneron colleague Wilson, shares how we choose the right process to meet each patients’ unique needs. | Regeneron
1:30
Patients are the key to our clinical trial success. Our Regeneron colle…
2K viewsFeb 9, 2021
FacebookRegeneron
What is Regeneron: 5 things to know about the Westchester-based pharmaceutical company
What is Regeneron: 5 things to know about the Westchester-base…
Oct 7, 2020
lohud.com
Roche, Regeneron link up on antibodies
1:03
Roche, Regeneron link up on antibodies
11.1K viewsAug 19, 2020
YahooReuters Videos
0:15
2.4K views · 26 reactions | We are proud to announce that the U.S. F…
2K views3 weeks ago
FacebookRegeneron
1:00
608K views · 385 reactions | Meet Jean, whose childhood passion fo…
608.2K views1 week ago
FacebookRegeneron
0:31
Through clinical trials, we can answer more questions, develop …
124.7K views10 months ago
FacebookRegeneron
0:22
1.2K views · 69 reactions | Our Automated Biobanking Core grou…
2K views3 weeks ago
FacebookRegeneron
0:10
58K views · 35 reactions | A person's atopic dermatitis (AD) sh…
58.5K views2 weeks ago
FacebookRegeneron
1:26
232K views · 80 reactions | Talk to your doctor to see if a clinical tria…
222.1K views1 week ago
FacebookRegeneron
0:08
You are part of the future of healthcare. Learn how your involv…
275.6K views4 months ago
FacebookRegeneron
0:19
15 reactions | It may be National Family Caregivers Month, but care…
2K views3 weeks ago
FacebookRegeneron
0:30
2.1K views · 811 reactions | At Regeneron, we move science to m…
262.1K views1 week ago
FacebookRegeneron
0:07
20 reactions | Having trouble completing everyday tasks due to …
2K views3 weeks ago
FacebookRegeneron
0:11
171 reactions · 20 shares | Our knowledge of the body is ever-cha…
298.7K views2 weeks ago
FacebookRegeneron
0:36
25K views · 42 reactions | AD can affect anyone, even professional a…
25.9K views3 weeks ago
FacebookRegeneron
1:22
107K views · 331 reactions | In collaboration with Sanofi Genzym…
107.1K views1 week ago
FacebookRegeneron
2:00
3.2K views · 131 reactions | Regeneron immunology expert, Ja…
3.3K views3 weeks ago
FacebookRegeneron
1:59
151 reactions · 39 shares | Our President and Chief Scientist, Geo…
793.8K views2 weeks ago
FacebookRegeneron
0:23
4K views | The holiday season is a good time to check in with loved o…
4.1K views1 week ago
FacebookRegeneron
0:09
We’re helping to build a legacy that sparks hope through clinical trials…
4.9K views4 months ago
FacebookRegeneron
1:05
8.2K views · 125 reactions | Regeneron is pursuing U.S. appro…
8.2K views2 weeks ago
FacebookReuters
5:15
6.8K views · 100 reactions | Regeneron just inked a deal with t…
6.9K views1 week ago
FacebookCNBC Fast Money
0:20
49 reactions | At Regeneron, our science-first mindset guides ever…
69K views6 days ago
FacebookRegeneron
1:48
By harnessing the potential of genetic research and technologies…
40.8K views10 months ago
FacebookRegeneron
2:55
12 reactions | Innovative science demands Diversity, Equity and...
2K views2 weeks ago
FacebookRegeneron
See more videos
Static thumbnail place holder